Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Anaphylactic shock | postmarketing | x | ||
| Angioedema | postmarketing | x | ||
| Asthma | postmarketing | x | ||
| Hypersensitivity | postmarketing | x | ||
| Pruritus | postmarketing | x | x | |
| Shock | postmarketing | x | ||
| Urticaria | postmarketing | x | ||
| Respiratory distress | postmarketing | x | ||
| Localised oedema | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Ascites chylous | x | x | ||
| Chylothorax | x | x | ||
| Chyluria | x | x | ||
| Lymphoedema | x | x | ||
| Metastatic neoplasm | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |